Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Claritev ( (CTEV) ) has issued an announcement.
Claritev Corporation disclosed that it received a confidential grand jury subpoena from the U.S. Department of Justice’s Antitrust Division in August 2024 related to an investigation concerning health insurance. The company stated it has fully cooperated over the subsequent two years and emphasized that the DOJ has not informed Claritev that it is a target of the probe.
The company’s disclosure came after a May 14, 2026 article alleged that the DOJ had launched a criminal antitrust investigation into Claritev. Claritev framed the filing as a Regulation FD compliance step and stressed its continuing focus on collaborating across the healthcare ecosystem to advance more transparent and affordable healthcare for consumers.
The most recent analyst rating on (CTEV) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Claritev stock, see the CTEV Stock Forecast page.
Spark’s Take on CTEV Stock
According to Spark, TipRanks’ AI Analyst, CTEV is a Neutral.
The score is held down primarily by stressed fundamentals (negative equity, high debt, and ongoing net losses) despite improving revenue and positive operating cash flow. Technicals remain weak with the stock far below key moving averages. The latest earnings call and recent corporate actions are positive (raised revenue guide, strong bookings/pipeline, buyback authorization) but are not yet enough to offset the balance-sheet and profitability risks.
To see Spark’s full report on CTEV stock, click here.
More about Claritev
Claritev Corporation operates in the healthcare sector, working with clients and partners across the broader health insurance and healthcare ecosystem. The company focuses on solutions intended to make healthcare more transparent, accessible and affordable for consumers, positioning itself as an enabler of greater clarity and efficiency in healthcare services and pricing.
Average Trading Volume: 187,504
Technical Sentiment Signal: Sell
Current Market Cap: $236.5M
Find detailed analytics on CTEV stock on TipRanks’ Stock Analysis page.